4.7 Article

Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival

Dominik Bettinger et al.

Summary: The new Freiburg index of post-TIPS survival (FIPS) score, incorporating age, bilirubin, albumin and creatinine, accurately identifies high-risk patients and predicts post-TIPS survival. However, the FIPS score shows inadequate prognostic discrimination in patients with early TIPS implantation.

JOURNAL OF HEPATOLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS

Wenzhe Fan et al.

Summary: DEB-TACE is safe and effective in HCC patients with a TIPS and potentially superior to cTACE in terms of complications, liver toxicities, OS, TTP, and ORR.

EUROPEAN RADIOLOGY (2021)

Article Gastroenterology & Hepatology

Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study

Justin Richard Boike et al.

Summary: This study analyzed the risk factors for post-TIPS mortality and liver transplantation, finding that the relationship with MELD-Na varies depending on the indication for TIPS.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Efficacy and safety of transjugular intrahepatic portosystemic shunt combined with transcatheter embolization/chemoembolization in hepatocellular carcinoma with portal hypertension and arterioportal shunt

Hai-lin Lu et al.

Summary: TIPS combined with TAE/TACE shows promising efficacy and safety in patients with HCC accompanied by portal hypertension and APS. It significantly improves APS, enhances objective response rate of HCC, but may be associated with liver function damage.

ABDOMINAL RADIOLOGY (2021)

Article Oncology

Hepatobiliary Cancers, Version 2.2021

Al B. Benson III et al.

Summary: The NCCN Guidelines for Hepatobiliary Cancers provide recommendations for screening, diagnosis, staging, treatment, and management of HCC, gallbladder cancer, and cancer of the bile ducts. A multidisciplinary evaluation is crucial for determining optimal treatment strategies, with significant advancements in systemic treatment of HCC beyond traditional options like sorafenib.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Article Gastroenterology & Hepatology

The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma

David J. Pinato et al.

JOURNAL OF HEPATOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Transjugular Intrahepatic Portosystemic Shunt for Portal Hypertension in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Bin Qiu et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2017)

Article Gastroenterology & Hepatology

Refining prognosis after trans-arterial chemo-embolization for hepatocellular carcinoma

Alberta Cappelli et al.

LIVER INTERNATIONAL (2016)

Article Cardiac & Cardiovascular Systems

Outcomes of Locoregional Tumor Therapy for Patients with Hepatocellular Carcinoma and Transjugular Intrahepatic Portosystemic Shunts

Siddharth A. Padia et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Characterization of Liver Function Parameter Alterations After Transjugular Intrahepatic Portosystemic Shunt Creation and Association With Early Mortality

Leigh C. Casadaban et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Hepatotoxicity after Transarterial Chemoembolization and Transjugular Intrahepatic Portosystemic Shunt: Do Two Rights Make a Wrong?

Maureen P. Kohi et al.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2013)

Review Cardiac & Cardiovascular Systems

Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical Recommendations

Riccardo Lencioni et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)

Article Gastroenterology & Hepatology

Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma

Nicola Personeni et al.

JOURNAL OF HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis

Moon Young Kim et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)

Review Cardiac & Cardiovascular Systems

Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies

Laura Marelli et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2007)

Review Gastroenterology & Hepatology

The Model for End-stage Liver Disease (MELD)

Patrick S. Kamath et al.

HEPATOLOGY (2007)

Article Cardiac & Cardiovascular Systems

Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts

I. Kaare Tesdal et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2006)

Review Gastroenterology & Hepatology

Management of hepatoceullular carcinoma

J Bruix et al.

HEPATOLOGY (2005)